Psychedelic Inequities and Unexplored Risk: Colonization, Commercialization, and Regulation
This piece identifies three interrelated topics that warrant scrutiny as drivers of psychedelic racial health inequities.

This piece identifies three interrelated topics that warrant scrutiny as drivers of psychedelic racial health inequities.
In short, 109’s creators’ stated intent to make psilocybin therapy accessible to help the growing mental health care crisis has resulted in a policy that doesn’t allow for any of it.
As a historian of psychoactive pharmaceuticals in the 20th century U.S., I see history rhyming in potentially dangerous ways in the current psychedelic boom.
Neglected tropical diseases were at the forefront of a recent convening on human health and climate change.
The calculus involved in revoking the shaken baby syndrome diagnosis needs careful evaluation.
Algorithms used in health care have the potential to improve health outcomes but are susceptible to racial bias.